Search

Author/Creator Perren, Timothy

1. 30-day mortality after systemic anticancer treatment for breast and lung cancer in England: a population-based, observational study. Issue 9 (September 2016)

Authors:
Wallington, Michael; Saxon, Emma B; Bomb, Martine; Smittenaar, Rebecca; Wickenden, Matthew; McPhail, Sean; Rashbass, Jem; Chao, David; Dewar, John; Talbot, Denis; Peake, Michael; Perren, Timothy; Wilson, Charles; Dodwell, David
Journal:
Lancet oncology
Issue:
Volume 17:Issue 9(2016:Sep.)
Page Start:
1203
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Clinical effectiveness of olaparib monotherapy in germline BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: phase IIIb LUCY interim analysis. (July 2021)

Authors:
Gelmon, Karen A.; Fasching, Peter A.; Couch, Fergus J.; Balmaña, Judith; Delaloge, Suzette; Labidi-Galy, Intidhar; Bennett, James; McCutcheon, Susan; Walker, Graham; O'Shaughnessy, Joyce; Timcheva, Constanta; Tomova, Antoaneta; Eisen, Andrea; Gelmon, Karen; Lemieux, Julie; Bazan, Fernando; Bourge...
Journal:
European journal of cancer
Issue:
Volume 152(2021)
Page Start:
68
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Cost-effectiveness analysis of the Oncotype DX Breast Recurrence Score test in node-positive early breast cancer. (31st December 2022)

Authors:
Berdunov, Vladislav; Millen, Steve; Paramore, Andrew; Hall, Peter; Perren, Timothy; Brown, Rebecca; Griffin, Jane; Reynia, Sarah; Fryer, Nina; Longworth, Louise
Journal:
Journal of medical economics
Issue:
Volume 25:Number 1(2022)
Page Start:
591
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. High EMSY expression defines a BRCA‐like subgroup of high‐grade serous ovarian carcinoma with prolonged survival and hypersensitivity to platinum. Issue 16 (2nd June 2019)

Authors:
Hollis, Robert L.; Churchman, Michael; Michie, Caroline O.; Rye, Tzyvia; Knight, Laura; McCavigan, Andrena; Perren, Timothy; Williams, Alistair R. W.; McCluggage, W. Glenn; Kaplan, Richard S.; Jayson, Gordon C.; Oza, Amit; Harkin, D. Paul; Herrington, C. Simon; Kennedy, Richard; Gourley, Charlie
Journal:
Cancer
Issue:
Volume 125:Issue 16(2019)
Page Start:
2772
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial. Issue 9990 (18th July 2015)

Authors:
Kehoe, Sean; Hook, Jane; Nankivell, Matthew; Jayson, Gordon C; Kitchener, Henry; Lopes, Tito; Luesley, David; Perren, Timothy; Bannoo, Selina; Mascarenhas, Monica; Dobbs, Stephen; Essapen, Sharadah; Twigg, Jeremy; Herod, Jonathan; McCluggage, Glenn; Parmar, Mahesh; Swart, Ann-Marie
Journal:
Lancet
Issue:
Volume 386:Issue 9990(2015)
Page Start:
249
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Weekly platinum-based chemotherapy versus 3-weekly platinum-based chemotherapy for newly diagnosed ovarian cancer (ICON8): quality-of-life results of a phase 3, randomised, controlled trial. Issue 7 (July 2020)

Authors:
Blagden, Sarah P; Cook, Adrian D; Poole, Christopher; Howells, Lesley; McNeish, Ian A; Dean, Andrew; Kim, Jae-Weon; O'Donnell, Dearbhaile M; Hook, Jane; James, Elizabeth C; White, Ian R; Perren, Timothy; Lord, Rosemary; Dark, Graham; Earl, Helena M; Hall, Marcia; Kaplan, Richard; Ledermann, Jonat...
Journal:
Lancet oncology
Issue:
Volume 21:Issue 7(2020)
Page Start:
969
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗